Review article: pharmacological treatment of hepatorenal syndrome.

about

Clinical manifestations of portal hypertension Ischaemic complications of Glypressin in liver disease: a case series Renal dysfunction in liver cirrhosis.Evaluation and management of patients with refractory ascites.Hepatorenal Syndrome: Diagnosis and Treatment - newsreel.

P2860

Q24633762-6F52EABE-F93F-47D2-9B9C-E634C121F961 Q36102565-448F6543-DC80-4234-880E-A0FF1A60AAF1 Q36369769-30D70B05-9339-4CA1-BC8C-CA1184CA3209 Q37122130-2365EEB0-1DAA-490C-BF88-9C82E56764CE Q38961705-3295A7A8-7C35-4871-BE89-CA0FE8BAE98D

P2860

Review article: pharmacological treatment of hepatorenal syndrome.

Item

http://www.wikidata.org/entity/Q35873840

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh-hant

name

Review article: pharmacological treatment of hepatorenal syndrome.

@ast

Review article: pharmacological treatment of hepatorenal syndrome.

@en

type

Item

label

Review article: pharmacological treatment of hepatorenal syndrome.

@ast

Review article: pharmacological treatment of hepatorenal syndrome.

@en

prefLabel

Review article: pharmacological treatment of hepatorenal syndrome.

@ast

Review article: pharmacological treatment of hepatorenal syndrome.

@en

P1476

Review article: pharmacological treatment of hepatorenal syndrome.

@en

P2093

Ginès P

http://www.w3.org/2001/XMLSchema#string

Guevara M

http://www.w3.org/2001/XMLSchema#string

Terra C

http://www.w3.org/2001/XMLSchema#string

Torre A

http://www.w3.org/2001/XMLSchema#string

P2860

Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide.

Long-term therapy and retreatment of hepatorenal syndrome type 1 with ornipressin and dopamine.

Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome.

Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study.

Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club.

Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion.

Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis.

Electrolyte and circulatory changes in terminal liver failure.

Clinical course, predictive factors and prognosis in patients with cirrhosis and type 1 hepatorenal syndrome treated with Terlipressin: a retrospective analysis.

Ascites and hepatorenal syndrome in cirrhosis: pathophysiological basis of therapy and current management.

P304

57-62; discussion 63-4

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2036.2004.02115.X

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

20 Suppl 3

http://www.w3.org/2001/XMLSchema#string

P577

2004-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8377799

http://www.w3.org/2001/XMLSchema#string

P698

15335404

http://www.w3.org/2001/XMLSchema#string

Review article: pharmacological treatment of hepatorenal syndrome.

about

P2860

P2860

Review article: pharmacological treatment of hepatorenal syndrome.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P5875

P698